Trials / Terminated
TerminatedNCT06053892
AR US Versus sUS or Fluoroscopic Injections for Shoulder Punction
Comparison of Time for Prucedure, and Effectiveness Between Augmented Reality Enhanced Ultrasound-guided Versus Standard Ultrasound or Fluoroscopic Injections
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- Balgrist University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The goal of this clinical trial is to prospectively evaluate the potential benefits of injections with Augmented Reality enhanced Ulrasound versus standard Ultrasound or fluoroscopy participants where assigend for fluoroscopic joint injections oder for Ultrasound guided injection. The main question\[s\] it aims to answer are: * The primary objective is to evaluate the duration of the different interventions * the count of needle passes * assess the reduction of radiation exposure using AR US rather than fluoroscopic guidance for joint injections
Detailed description
Patients assigned for standard Ultrasound or fluoroscopic joint injection are informed about the trial. Participants are randomly assigned to the study or control intervention. 1:1 randomization is used. In both groups, data on duration of the intervention, count of needle passes, correctness of injection location and radiation exposure will be collected. The outcome measures will be compared between the groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Puncture | Shoulder puncture with the newly designed technique using AR to overlie the US image to the imaged anatomical structures in comparision to standard US and flurosopic-guidance. |
Timeline
- Start date
- 2023-06-13
- Primary completion
- 2025-01-31
- Completion
- 2025-01-31
- First posted
- 2023-09-26
- Last updated
- 2025-09-08
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT06053892. Inclusion in this directory is not an endorsement.